Literature DB >> 29901745

Patient features and survival of pediatric aplastic anemia in the USA: a large institution experience.

M J Hossain1,2, S Xie1.   

Abstract

BACKGROUND: We performed the first epidemiologic investigation to examine association of demographics and clinical characteristics at diagnosis, as well as health care expense coverage, with survival of US children with aplastic anemia (AA).
METHODS: We obtained electronic medical record data of 1140 children aged 0-19 years diagnosed with AA followed at a pediatric health system between 2004 and 2014. Kaplan-Meier curve and Cox proportional hazards regressions were used.
RESULTS: Self-pay patients had a mortality risk five times higher than that of those insured by publicly funded insurance (hazards ratio, 95% CI: 6.0, 3.7-9.8). Other features associated with higher mortality risk include pancytopenia (hazards ratio, referent: 4.2, constitutional AA); underweight (2.0, normal-weight); platelet count <50 × 109/l (1.3, ≥50 × 109/l); male sex (1.3, female); and ages at diagnosis 6-11, 11-16 and 16-19 years (1.6, 1.9, 2.3, 1-3 years), respectively.
CONCLUSIONS: Self-pay was the strongest prognostic factor for pediatric AA mortality. Older age, pancytopenia, underweight, male sex and lower platelet count were also associated with increased risk of mortality. These findings may be useful for providers, researchers and policymakers to ensure effective health care delivery to this population and to motivate future etiologic research and establishment of a surveillance registry.
© The Author(s) 2018. Published by Oxford University Press on behalf of Faculty of Public Health. All rights reserved. For permissions, please e-mail: journals.permissions@oup.com.

Entities:  

Keywords:  blood and immune disorders; epidemiology; young people

Mesh:

Year:  2019        PMID: 29901745      PMCID: PMC6662081          DOI: 10.1093/pubmed/fdy104

Source DB:  PubMed          Journal:  J Public Health (Oxf)        ISSN: 1741-3842            Impact factor:   2.341


  26 in total

1.  Cyclophosphamide and antithymocyte globulin as a conditioning regimen for allogeneic marrow transplantation in patients with aplastic anaemia: a long-term follow-up.

Authors:  Christoph Kahl; Wendy Leisenring; H Joachim Deeg; Thomas R Chauncey; Mary E D Flowers; Paul J Martin; Jean E Sanders; Rainer Storb
Journal:  Br J Haematol       Date:  2005-09       Impact factor: 6.998

2.  Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT).

Authors:  Anna Locasciulli; Rosi Oneto; Andrea Bacigalupo; Gerard Socié; Elisabeth Korthof; Albert Bekassy; Hubert Schrezenmeier; Jakob Passweg; MoniKa Führer
Journal:  Haematologica       Date:  2007-01       Impact factor: 9.941

3.  Effect of race on outcomes after allogeneic hematopoietic cell transplantation for severe aplastic anemia.

Authors:  Michael J Eckrich; Kwang-Woo Ahn; Richard E Champlin; Peter Coccia; Kamar Godder; John Horan; David Margolis; H Joachim Deeg; Mary Eapen
Journal:  Am J Hematol       Date:  2013-11-15       Impact factor: 10.047

4.  Epidemiologic and HLA antigen profile in patients with aplastic anemia.

Authors:  Mehwesh Taj; Tahir Sultan Shamsi; Saqib Hussain Ansari; Tasneem Farzana; Arshi Nazi; Muhammad Nadeem; Rizwan Nabi Qureshi; Kashif Sheikh; Jawwad Hasan Kazmi
Journal:  J Coll Physicians Surg Pak       Date:  2014-08       Impact factor: 0.711

5.  Underinsurance among children in the United States.

Authors:  Michael D Kogan; Paul W Newacheck; Stephen J Blumberg; Reem M Ghandour; Gopal K Singh; Bonnie B Strickland; Peter C van Dyck
Journal:  N Engl J Med       Date:  2010-08-26       Impact factor: 91.245

6.  Impact of age on outcomes after bone marrow transplantation for acquired aplastic anemia using HLA-matched sibling donors.

Authors:  Vikas Gupta; Mary Eapen; Ruta Brazauskas; Jeanette Carreras; Mahmoud Aljurf; Robert Peter Gale; Gregory A Hale; Osman Ilhan; Jakob R Passweg; Ollé Ringdén; Mitchell Sabloff; Hubert Schrezenmeier; Gerard Socié; Judith C W Marsh
Journal:  Haematologica       Date:  2010-09-17       Impact factor: 9.941

7.  Long-term outcome after bone marrow transplantation for severe aplastic anemia.

Authors:  Lionel Ades; Jean-Yves Mary; Marie Robin; Christèle Ferry; Raphael Porcher; Hélène Esperou; Patricia Ribaud; Agnès Devergie; Richard Traineau; Eliane Gluckman; Gérard Socié
Journal:  Blood       Date:  2003-12-04       Impact factor: 22.113

8.  Acute lymphoblastic leukemia of childhood presenting as aplastic anemia: report of two cases.

Authors:  Laura Villarreal-Martínez; José Carlos Jaime-Pérez; Marisol Rodríguez-Martínez; Oscar González-Llano; David Gómez-Almaguer
Journal:  Rev Bras Hematol Hemoter       Date:  2012

Review 9.  Acquired aplastic anemia in childhood.

Authors:  Eva C Guinan
Journal:  Hematol Oncol Clin North Am       Date:  2009-04       Impact factor: 3.722

Review 10.  Acquired aplastic anemia in children: incidence, prognosis and treatment options.

Authors:  Anna Locasciulli
Journal:  Paediatr Drugs       Date:  2002       Impact factor: 3.022

View more
  1 in total

1.  Utility of Bone Marrow Examination in Pediatric Age Group: Experience of a Tertiary Healthcare Centre in India.

Authors:  Meenakshi Balasubramanian; Niyati N Sangoi
Journal:  Cureus       Date:  2022-07-20
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.